Navigation Links
Synthetic Biologics Reports Third Quarter 2012 Financial Results
Date:11/14/2012

filings with the SEC. The information in this release is provided only as of the date of this release, and Synthetic Biologics undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

 Synthetic Biologics, Inc. and Subsidiaries(in thousands, except share data)Condensed Consolidated Balance SheetsSeptember 30,December 31,20122011(Unaudited)(Audited)AssetsCash

$
4,577$
,678Accounts receivable, net

122405Other

15116Assets of discontinued operations

-23Property and equipment, net

249323Long-term note receivable

700-Deposits and other assets

2731Total assets

$
5,826$
7,476Liabilities and Stockholders' EquityCurrent liabilities

$
417$
417Stockholders' equity

5,4097,059Total liabilities and stockholders' equity

$
5,826$
7,476 Condensed Consolidated Statements of Operations (Unaudited)For the three months ended
September 30,For the nine months ended
September 30,2012201120122011Operating Costs and ExpensesGeneral and administrative

$
,073$
582$
3,717$
2,339Research and development

7632891,696801Total operating costs and expenses

1,8368715,4133,140Loss from Continuing Operations(1,836)(871)(5,413)(3,140)Other Income (Expense)Warrant expense  

---(1,492)Change in fair value of warrant liability

-(165)-(242)Other income (expense)

1062255Total other income (expense), net

10(159)22(1,679)Loss from Continuing Operations(1,826)(1,030)(5,391)(4,819)Income (Loss) from Discontinued Operations(104)(68)389(145)Net Loss and Comprehensive Loss$
(1,930)$
(1,098)$
(5,002)$
(4,964)Net Income (Loss) Per Share - Basic and DilutiveContinuing Operations

$
(0.05)$
(0.04)$
(0.16)$
(0.18)Discontinued Oper
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Synthetic Biologics to Acquire Clinical-Stage C. difficile Infectious Disease Program
2. Taming mavericks: Stanford researchers use synthetic magnetism to control light
3. Synthetic Biologics Completes $10.8 Million Private Placement Financing
4. Synthetic Biologics Announces $10.8 Million Financing
5. Synthetic Genomics Inc. Purchases Patent Portfolio from Febit Holding GmbH
6. Synthetic Biology Market is Expected to Reach USD 16.7 Billion Globally in 2018: Transparency Market Research
7. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
8. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
9. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
10. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
11. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced ... complete 2015 first quarter financial statements and MD&A have been filed ... March 31,(in CDN$,000 except per share data) , 2015 ... 1,974 Gross profit , 1,531 , 329 Ebitda* ... 528 , (531) Basic earnings (loss) per share ...
(Date:6/1/2015)... Regis Technologies, Inc. is a ... stationary phases (CSPs) for analytical and preparative chromatography ... presenting solutions for new clients, Regis implemented a ... addition to its core expertise in chiral chromatography ... tackle projects for the scale clients need–from milligram ...
(Date:6/1/2015)... , June 1, 2015  Neogen Corporation (NASDAQ: NEOG ... Sterling Test House, a leading commercial food testing laboratory based ... acquired laboratory will serve as a base for the company,s ... Sterling Test House was incorporated in 1990, ... the food safety and water quality testing for major hotels ...
(Date:6/1/2015)... BATON ROUGE, La. , June 1, 2015 /PRNewswire/ ... a Phase II trial of lead candidate EP-100 in ... targeted membrane-disrupting peptide designed to seek and destroy cancer ... their surfaces. LHRH receptors are over-expressed in a wide ... randomized, multi-center Phase II trial of EP-100 ...
Breaking Biology Technology:Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3Neogen acquires India food safety company 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3
... , , SANTA CLARA, Calif., Sept. 8 ... Board: APNO) today announced that they have entered into a ... Cell Biosciences for $1.50 per share or approximately $17.9 million ... analysis business to include a global infrastructure and a broad ...
... LAIYANG, China, Sept. 8 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, ... pharmaceutical company with its principal operations in the People,s,Republic ... year 2009. The Company expects to meet or ... and operating income of $40 to $43 million for ...
... , , ... systems biology tools company, announced today that Proteostasis Therapeutics has ... Therapeutics is the first company dedicated to the discovery of ... Network. The Proteostasis Network maintains the body,s natural balance ...
Cached Biology Technology:Cell Biosciences Signs Agreement to Acquire Alpha Innotech 2Cell Biosciences Signs Agreement to Acquire Alpha Innotech 3Cell Biosciences Signs Agreement to Acquire Alpha Innotech 4Cell Biosciences Signs Agreement to Acquire Alpha Innotech 5Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009 2GeneGo Licenses MetaCore to Proteostasis Therapeutics 2
(Date:5/27/2015)...   Codonics (codonics.com), a global ... documentation solutions and Omnicell  (omnicell.com), a ... is pleased to announce their state of ... System® (SLS), an award-winning FDA class 2 ... Anesthesia Workstation, helps prevent medication errors, streamlines ...
(Date:5/22/2015)... CT , May 22, 2015  NXT-ID, Inc. (NASDAQ: ... June 1st, it will be ending its promotional pricing and ... . Laurence Savin , Head of Marketing ... exclusive promotional pricing until the end of May. To get ... wocketwallet.com/invite and when we open the store on June 1, ...
(Date:5/21/2015)... -- The Sync Project™ , a global collaboration ... announced a collaborative partnership with Berklee,s Institute for ... collaboration on original research, joint course development and an ... The Sync Project and BerkleeICE are exploring the launch ... 2015-2016 academic year.  The course will ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... dedicated to exploring the science of life, is set to ... carry long-form features, articles and films that tell the stories ... will be free to read, and text features will be ... be reproduced and distributed freely across other platforms. ...
... have discovered the key role of a protein in shutting ... scientists for half a century. The study, published today ... outline the role of actin, a protein, in shutting down ... which cells absorb molecules that are too large to pass ...
... heartier appetite is linked to more rapid infant growth and ... in JAMA Pediatrics today (Monday). , The studies ... of appetite, namely lower satiety responsiveness (a reduced urge to ... responsiveness (an increased urge to eat in response to the ...
Cached Biology News:New digital publication Mosaic explores the science of life 2Mitosis mystery solved as role of key protein is confirmed 2Why tackling appetite could hold the key to preventing childhood obesity 2
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Mfr ...
... Single Cell Whole Genome Amplification Kit ... random fragmentation of genomic DNA and ... to PCR-amplifiable library molecules flanked by ... by PCR amplification of the library ...
Rabbit Anti-Mouse Ym1 Polyclonal Antibody,...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Biology Products: